https://orcid.org/0000-0002-2370-4823
References
- Kohsaka S, Katada J, Saito K, Terayama Y. Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data. Curr Med Res Opin. 2018;34(9):1627–1634. doi:10.1080/03007995.2018.147828229772946
- Koretsune Y, Yamashita T, Yasaka M, et al. Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: a claims database analysis. J Cardiol. 2019;73(3):204–209. doi:10.1016/j.jjcc.2018.09.00430477926
- Urushihara H, Taketsuna M, Liu Y, et al. Increased risk of acute pancreatitis in patients with type 2 diabetes: an observational study using a Japanese hospital database. PLoS One. 2012;7(12):e53224. doi:10.1371/journal.pone.005322423300896
- Kitazawa T, Matsumoto K, Fujita S, Seto K, Hasegawa T. Cost analysis of transplantation in Japan, performed with the use of the national database. Transplant Proc. 2017;49(1):4–9. doi:10.1016/j.transproceed.2016.10.00728104154
- Hayashi S, Noda T, Kubo S, et al. Variation in fracture risk by season and weather: a comprehensive analysis across age and fracture site using a National Database of Health Insurance claims in Japan. Bone. 2019;120:512–518. doi:10.1016/j.bone.2018.12.01430576867
- Kosiborod M, Lam CSP, Kohsaka S, et al. Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study. J Am Coll Cardiol. 2018;71(23):2628–2639. doi:10.1016/j.jacc.2018.03.00929540325
- Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20(5):413–419. doi:10.2188/jea.JE2009006620699602
- Ishii M. DRG/PPS and DPC/PDPS as prospective payment systems. Japan Med Assoc J. 2012;55(4):279–291.
- Seino Y, Yabe D, Yasui A et al. EMPagliflozin compaRative effectIveness and safety (emprise) program; study design in Japan. paper presented at: the Japan Society ofDiabetic Complications. 34th Annual Meeting 2019; Japan: Osaka.
- Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27(10):476–482. doi:10.1016/j.je.2016.09.00928142051
- Ando T, Ooba N, Mochizuki M, et al. Positive predictive value of ICD-10 codes for acute myocardial infarction in Japan: a validation study at a single center. BMC Health Serv Res. 2018;18(1):895. doi:10.1186/s12913-018-3727-030477501
- Ooba N, Setoguchi S, Ando T, et al. Claims-based definition of death in Japanese claims database: validity and implications. PLoS One. 2013;8(5):e66116. doi:10.1371/journal.pone.006611623741526
- Medical Information System Development Center [homepage on the Internet]. [Standard disease name master for ICD-10]. Available from: http://www2.medis.or.jp/stdcd/byomei/index.html. AccessedApril 1, 2020. Japanese.
- Koram N, Delgado M, Stark JH, Setoguchi S, de Luise C. Validation studies of claims data in the Asia-Pacific region: a comprehensive review. Pharmacoepidemiol Drug Saf. 2019;28(2):156–170. doi:10.1002/pds.v28.230022560
- Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–242. doi:10.1002/pds.208721351304
- Park TH, Choi JC. Validation of stroke and thrombolytic therapy in Korean National Health Insurance claim data. J Clin Neurol. 2016;12(1):42–48. doi:10.3988/jcn.2016.12.1.4226365022
- Nedkoff L, Knuiman M, Hung J, Sanfilippo FM, Katzenellenbogen JM, Briffa TG. Concordance between administrative health data and medical records for diabetes status in coronary heart disease patients: a retrospective linked data study. BMC Med Res Methodol. 2013;13(1):121. doi:10.1186/1471-2288-13-12124079345